Darbepoetin alfa biosimilar (Chong Kun Dang)

达依泊汀α生物类似药（Chong Kun Dang）

Report date: 2022/03/11 16:09:06

Base Information

Drug NameDarbepoetin alfa biosimilar (Chong Kun Dang)
Drug Alias NameDarbepoetin alfa生物类似药 (Chong Kun Dang)Darbepoetin alfa biosimilar (Chong Kun Dang)darbepoetin-alfa biosimilarCKD-11101
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/09/20
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesMenagen Pharmaceutical Industries LLCMylan Nv
Inactive CompaniesChong Kun Dang Pharmaceutical Corp
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA02
Related LinksWikipediaDrugBankKEGG